Quarterly report on Consolidated Results for The Financial Period Ended 31/03/2009
26 May 2009
 

    INDIVIDUAL PERIOD
    CUMULATIVE PERIOD
       
    CURRENT YEAR QUARTER
    PRECEDING YEAR
    CORRESPONDING
    QUARTER
    CURRENT YEAR TO DATE
    PRECEDING YEAR
    CORRESPONDING
    PERIOD
       
    31/03/2009
    31/03/2008
    31/03/2009
    31/03/2008
       
    RM'000
    RM'000
    RM'000
    RM'000
    1   Revenue
    27,665
    27,473
    27,665
    27,473
    2 Profit/(loss) before tax
    9,369
    9,846
    9,369
    9,846
    3 Profit/(loss) for the period
    6,978
    7,312
    6,978
    7,312
    4 Profit/(loss) attributable to ordinary equity holders of the parent
    6,978
    7,312
    6,978
    7,312
    5 Basic earnings/(loss) per share (sen)
    5.03
    5.27
    5.03
    5.27
    6 Proposed/Declared dividend per share (sen)
    0.00
    0.00
    0.00
    0.00








    AS AT END OF CURRENT QUARTER
    AS AT PRECEDING FINANCIAL YEAR END
    7
    Net assets per share attributable to ordinary equity holders of the parent (RM)
    0.9900
    0.9400


    Note: For full text of the above announcement, please access Bursa Malaysia website at www.bursamalaysia.com

     
     
      Solutions by WEBSEImportant legal information - please read the Privacy Policy & Disclaimer before proceeding.
    Copyright © 2010 CCM Duopharma Biotech Bhd. All Rights Reserved.